Search Results

350 results found for 'wzg0i8kf.tech'.

Global paediatric antiretroviral commitment-to-action

News | 10 June 2016
...a collaboration of UNITAID, the Clinton Health Access Initiative, Drugs for Neglected Diseases initiative, the Medicines Patent Pool and the World Health Organization (as technical partner) – and the Global...

view more
Malaria vector control commodities technology and market landscape – 1st edition

Publication

PDF: EN
Publications

Page
Unitaid’s online library includes, among other things, stories about our impact, summaries of our grant portfolios, technical reports and resolutions from the Unitaid Board....

view more
Charlotte Kristiansson

team leader, programme management Charlotte is from Sweden. She holds a PhD in international health and a bachelor’s degree in technology and biology. Charlotte has almost 20 years’ experience in...

view more
Unitaid statement on the MPP agreements for local production of generic versions of the oral COVID-19 antiviral nirmatrelvir

News | 24 March 2022
...the world’s population. Unitaid pays tribute to the MPP for these agreements, in line with WHO’s COVID-19 Technology Access Pool (C-TAP) principles for licensing, that will help expand access to...

view more
Unitaid and TB Alliance announce world’s first appropriate TB medicines for children in correct doses

News | 02 December 2015
...operates with support from Australia’s Department of Foreign Affairs and Trade, Bill & Melinda Gates Foundation, European Commission, Global Health Innovative Technology Fund, Irish Aid, Indonesia Health Fund, National Institute...

view more
Malaria diagnostics technology landscape – semi-annual update

Publication

PDF: EN
Unitaid partners with APLMA to drive malaria elimination in Asia Pacific by 2030

News | 02 July 2018
...innovation”, said Dr Ben Rolfe, CEO of the APLMA Secretariat. “It’s simple. We won’t eliminate malaria unless we get new recommended technologies to market fast and this is the gap...

view more

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.